HLN logo

HALEON PLC-ADR

HLNNYSE
🏆 #356 by market capUS Equity
$9.04▼ $0.13 (−1.42%)
Live
🔔
Track HLN
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 1.4%
7d▼ 2.3%
14d▼ 2.2%
30d▼ 10.5%
ytd▼ 10.7%
1y▲ 2.4%
🏦Market Cap
$39.81B
Mid Cap
📈Revenue Growth (YoY)
-1.8%
Declining
📊Gross Margin
65.6%
High
💵FCF Margin
10.6%
Healthy
⚖️P/S Ratio
2.7x
Cheap
Otter Score
80
Good

Trading Snapshot

Day Range
$8.99 – $9.09
52-Week Range
$8.65 – $11.28
Volume
$2.69B
Avg Volume
$3.18B
Shares Outstanding
4.40B
Next Earnings
Nov 15, 2026

Fundamentals Snapshot

Annual Revenue
$11.03B
Last Q Revenue
$5.64B
P/E Ratio
18.8
P/S Ratio
2.7x
EPS (TTM)
$0.36
Dividend Yield
2.15%
Dilution (1yr)
−2.8%

Why Investors Own HLN

  • ✓High-growth profile — revenue up +36.3% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 47% gross margin and 9% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

HLN logo

HALEON PLC-ADR

HLN
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$11.0B▼ −1.8% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
63.3%▲ +2.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$2.4B▲ +9.3% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$2.0B▼ −3.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
4.48B▼ −2.8% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$7.3B▲ +$635M YoY
StockOtter · stockotter.space

About HALEON PLC-ADR

Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Good
80/100

Analyst Ratings

ⓘ
Consensus
Buy
26 analysts
Strong Buy7
Buy12
Hold5
Sell2
Strong Sell0
Ratings as of Sep 2026

Latest News & Updates

🚀
Bloomberg·2h ago

HALEON PLC-ADR tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Bloomberg·5h ago

Analysts lift HLN price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Reuters·1d ago

HALEON PLC-ADR announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.